Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 4

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 3,001–4,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
3001aparc-DKTatlas rh area fusiformGCST900032701.00
3002Free cholesterol in large HDLGCST904977861.00
3003Administrative and legal statuses - NHS patient: not formally detained | Summary AdministrationUKBB000000121.00
3004Cholesteryl ester levels in large LDLGCST900928581.00
3005Other/unspecified dorsalgiaFING000011241.00
3006IDP dMRI TBSS L3 Middle cerebellar peduncleGCST900041711.00
3007Left-hemisphere limbic network to caudate white-matter structural connectivityGCST903027371.00
3008FOXO3/MAP3K5 ratioGCST903148801.00
3009Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900254341.00
3010Docosahexaenoic acid to total fatty acids percentageGCST905022850.99
3011IDP dMRI ProbtrackX ISOVF fmiGCST900045360.99
3012Treatment speciality of consultant (recoded) - Dermatology | Summary AdministrationUKBB000008300.99
3013Free cholesterol levels in very large HDLGCST900930080.99
3014Venous thromboembolismGCST903997440.99
3015Aniseed likingGCST900946890.99
3016IDP dMRI ProbtrackX ICVF ilf lGCST900043890.99
3017LTBP2/MYOC ratioGCST903153370.99
3018FGF23 levelsGCST900120220.99
3019GCG levelsGCST904693160.99
3020ARTN levelsGCST904683720.99
3021wg rh intensity-contrast parsopercularisGCST900038440.99
3022ROBO2/SFTPD ratioGCST903157850.99
3023Diabetes type 2 with peripheral circulatory (PheCode 250.25)GCST904756780.99
3024Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903027060.98
3025Chronic ischaemic heart disease | Ischaemic heart diseasesUKBB000001370.98
3026aseg lh intensity CaudateGCST900037690.98
3027DTI TBSS L1 Posterior limb of internal capsule RGCST903844460.98
3028CD69/PLXNA4 ratioGCST903138800.98
3029Insulin fold change during an oral glucose tolerance test (adjusted for BMI)GCST902675670.98
3030IDP T1 FAST ROIs R putamenGCST900025520.98
3031IDP dMRI ProbtrackX L3 ifo rGCST900043130.98
3032Operative procedures - Carpal tunnel release | Summary OperationsUKBB000005740.98
3033DAB2/FKBP1B ratioGCST903143620.98
3034BSG/PCDH1 ratioGCST903135350.98
3035Lysoalkylphosphatidylcholine (O-24:2) levelsGCST900254380.98
3036Chronic dermatitis due to solar radiation (PheCode 938.2)GCST904762880.97
3037COL18A1/RARRES2 ratioGCST903141690.97
3038Subjective well-beingGCST901048970.97
3039CA2/HMBS ratioGCST903135790.97
3040DTI TBSS FA Superior longitudinal fasciculus RGCST903844200.97
3041Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T202ECGU0002020.97
3042Brugada syndromeGCST900861580.97
3043IDP dMRI TBSS L2 Posterior corona radiata RGCST900041490.97
3044IDP dMRI TBSS FA Posterior thalamic radiation LGCST900039060.97
30451-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996520.97
3046rfMRI amplitudes (ICA100 node 12)GCST900046000.97
3047Total lipid levels in IDLGCST901326330.96
3048Blood cell traits latent factor 23 (white cell)GCST905592650.96
3049T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 88)GCST903209070.96
3050PRR4 levelsGCST904703380.96
3051Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T359ECGU0003590.96
3052Peripheral vascular diseaseGCST904752190.96
3053PDGFB/VEGFC ratioGCST903156350.96
3054IDP dMRI TBSS L3 External capsule RGCST900042030.96
3055Anemia of chronic disease (PheCode 285.2)GCST904757900.96
3056Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T218ECGA0002180.96
3057Membranous nephropathyGCST0100060.95
3058RILPL2 levelsGCST904704700.95
3059Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T199ECGU0001990.95
3060Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003590.95
30611-palmitoylglycerophosphoethanolamine levelsGCST902438350.95
3062Parkinson's diseaseFING000011500.95
3063Biological Grandparent (paternal): Coronary Artery / Coronary Heart DiseaseGCST904755480.95
3064DTI autoptx L3 ptr l tractGCST903852120.95
3065DCXR/GSTA1 ratioGCST903144370.95
3066T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118)GCST903206810.95
3067Other peripheral nerve disorders | neurologicalUKBB000006180.95
3068Repeated disturbing thoughts of stressful experience in past month | Traumatic eventsUKBB000007500.95
3069CD84/DAG1 ratioGCST903139100.95
3070Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organsUKBB000004250.94
3071Tobacco useFING000013650.94
3072Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T337ECGU0003370.94
3073IDP dMRI TBSS MD External capsule RGCST900040590.94
3074Loud music exposure frequency | HearingUKBB000004100.94
3075Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78ECGU0000780.93
3076Cholesterol levels in very small VLDLGCST900930280.93
3077Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivityGCST903027650.93
3078PALM2 levelsGCST904701520.93
3079ENTPD5 levelsGCST904691210.93
3080AK1/PEBP1 ratioGCST903132250.93
3081T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 100)GCST903209190.93
3082C3 levelsGCST902810410.93
3083rfMRI amplitudes (ICA100 node 2)GCST900045900.93
3084Treatment or medication use - amlodipine (UKB data field 20003_1140879802)GCST900421950.93
3085Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000001810.93
3086PLXNA4/SPRY2 ratioGCST903156870.93
3087Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST904760040.92
3088Disorders of lacrimal systemFING000004410.92
3089IDP dMRI ProbtrackX L1 unc lGCST900042710.92
3090Total lipids in large LDL (UKB data field 23531)GCST902696280.92
3091Average diameter for HDL particlesGCST901327020.92
3092L1CAM/SEZ6L ratioGCST903152660.92
3093IDP dMRI TBSS OD External capsule LGCST900044350.92
3094Multi-trait sex scoreGCST902701160.92
3095Concentration of IDL particles (UKB data field 23523)GCST902696200.92
3096Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276ECGU0002760.92
3097CDKN1A/YES1 ratioGCST903139800.92
3098Phospholipid levels in very large HDLGCST900930120.92
3099RNF43 levelsGCST904224820.92
3100Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470ECGA0004700.92
3101Disorders of ocular muscles, binocular movement, accommodation and refractionFING000004460.92
3102DTI autoptx L2 slf r tractGCST903851880.92
3103Abnormal heart sounds (PheCode 396)GCST904759160.91
3104Pain in limb (PheCode 773)GCST904762700.91
3105Total cholesterol levelsGCST900929850.91
3106Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131ECGU0001310.91
3107BAG6/WASF1 ratioGCST903134520.91
3108N6-acetyllysine levels in chronic kidney diseaseGCST902575310.91
3109Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80ECGA0000800.91
3110GLRX2 levelsGCST902412780.91
3111IDP dMRI TBSS L3 Posterior thalamic radiation LGCST900042000.91
3112BA-exvivo lh volume BA4pGCST900028400.91
3113Defects in the complement systemFING000003830.91
3114Sphingomyelin (d18:1/20:0, d16:1/22:0) levelsGCST902000010.91
3115T1 FreeSurfer a2009s lh G precentral volumeGCST903848440.91
3116Plasma 1-methylurate levels in chronic kidney diseaseGCST902642400.91
3117Free Cholesterol to Total Lipids in Large LDL percentageGCST904980070.91
3118Mean corpuscular hemoglobin concentrationGCST900187450.91
3119QC T1 inverse SNRGCST900063480.90
3120Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431ECGU0004310.90
3121rfMRI connectivity (ICA100 edge 1066)GCST900059190.90
3122CCL25 levelsGCST904685770.90
3123IDP dMRI ProbtrackX L2 unc rGCST900042990.90
3124Benign neoplasm of eye (PheCode 224)GCST904756260.90
3125Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491ECGA0004910.90
3126Hand grip strength left (UKB data field 46)GCST904681680.90
3127DTI TBSS L2 Sagittal stratum LGCST903845070.90
3128Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78ECGA0000780.90
3129aseg lh volume CerebralWhiteMatterGCST900026150.90
3130Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T350ECGU0003500.90
3131ENO2/SULT1A1 ratioGCST903146690.90
3132IDP dMRI ProbtrackX MD ilf rGCST900042340.90
3133Age-related eyesight deterioration (confirmatory factor analysis Factor 27)GCST903093610.89
3134Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027610.89
3135Monounsaturated fatty acid levelsGCST904990900.89
3136HydrocephalusFING000006280.89
3137GYS1/TIA1 ratioGCST903150040.89
3138Metabolonic lactone sulfate levelsGCST902002570.89
3139ChalazionFING000002670.88
3140aparc-a2009s lh area G-parietal-supGCST900033230.88
3141MFAP4 levelsGCST904698980.88
3142Retinal thickness (functional principal component 2)GCST904557220.88
3143LTBP3 levelsGCST904698150.88
3144Left ventricular end-diastolic volumeGCST902681240.88
3145DTI TBSS L2 Retrolenticular part of internal capsule RGCST903844960.88
3146Total free cholesterol levels (UKB data field 23419)GCST902695160.88
3147Cholesteryl esters in medium VLDL (UKB data field 23506)GCST902696030.88
3148Childhood maltreatmentGCST905518320.88
3149MPIG6B/PLXNA4 ratioGCST903154830.88
3150F9/FURIN ratioGCST903147470.88
3151Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466ECGA0004660.88
3152Phospholipids to total lipids ratio in large VLDLGCST900928770.88
3153Coronary atherosclerosis | circulatory systemUKBB000001520.88
3154IDP dMRI ProbtrackX ICVF ar rGCST900043760.88
3155CNTN5 levelsGCST904688070.87
3156GP1BB levelsGCST904693810.87
3157Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T343ECGU0003430.87
3158ANGPTL1 levelsGCST904683020.87
3159ERP29 levelsGCST900888430.87
3160Free cholesterol in medium VLDLGCST904989600.87
3161Cholesterol to Total Lipids in Small LDL percentageGCST904995640.87
3162Total free cholesterol levelsGCST900929880.87
3163Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccineGCST904486950.87
3164CD84/CDKN1A ratioGCST903139090.87
3165SVEP1 levelsGCST902429280.87
3166IDP dMRI ProbtrackX ISOVF cgc rGCST900045300.87
3167Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T348ECGU0003480.86
3168Acne (PheCode 706.1)GCST904762110.86
3169aparc-DKTatlas lh volume lateraloccipitalGCST900028710.86
3170Phospholipids in very large VLDLGCST905006470.86
3171Other chronic ischemic heart disease, unspecified (PheCode 411.8)GCST904759380.86
3172IDP dMRI ProbtrackX L3 ptr lGCST900043190.86
3173Nonischemic cardiomyopathyFING000008830.86
3174CCL5/CXCL3 ratioGCST903137000.86
3175Physical activity (Relative amplitude)GCST900614320.86
3176IDP T1 FAST ROIs R lingual gyrusGCST900025220.86
3177Triacylglycerol (54:0) [NL-18:0] levelsGCST900251730.86
3178CPA2 levelsGCST904688370.86
3179IDP dMRI ProbtrackX L2 ilf lGCST900042870.86
3180Fasting blood glucoseGCST0051860.86
3181HeterophoriaFING000006200.86
3182diastolic blood pressure (DBP, maximum, inv-normal transformed)GCST904752520.86
3183Unspecified acute lower respiratory infectionFING000013980.86
3184Fasting insulinGCST900022380.85
3185Total Sphingomyelin levelsGCST900258420.85
3186ATRN levelsGCST904684000.85
3187Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993350.85
3188DLL1/TGFBR2 ratioGCST903144990.85
3189Total lipids in large LDLGCST904980210.85
3190Cholesterol to Total Lipids in Large LDL percentageGCST904979290.85
3191CALCOCO1/PFKFB2 ratioGCST903136080.85
3192wg rh intensity-contrast supramarginalGCST900038570.85
3193Prescriptions - thiazide diuretic|diureticUKBB000007040.85
3194Memory loss or impairmentGCST904755440.85
3195IDP T1 FAST ROIs L ventral striatumGCST900025590.84
3196Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903026770.84
3197Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98ECGA0000980.84
3198Myocardial fractal dimension (slice 6)GCST900002920.84
3199Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000004430.84
3200ENPP2/TNFRSF11B ratioGCST903146720.84
3201Free Cholesterol in LDLGCST904983880.83
3202BA-exvivo rh area entorhinalGCST900032340.83
3203Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489ECGA0004890.83
3204Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levelsGCST903180130.83
3205Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2)GCST901329690.83
3206Non-cancer illness code, self-reported - high cholesterol | Medical conditionsUKBB000005160.83
3207NMT1 levelsGCST904700590.83
3208DTI TBSS L2 Uncinate fasciculus RGCST903845200.83
3209Free cholesterol levels in IDLGCST901326760.83
3210Cholesteryl esters in very small VLDL (UKB data field 23520)GCST902696170.83
3211Systolic blood pressure (standard GWA)GCST902673040.83
3212aparc-a2009s lh area S-precentral-sup-partGCST900033650.82
3213Severe hearing loss or partial deafness in one or both earsGCST904753850.82
3214NTPROBNP levelsGCST904700960.82
3215N-palmitoyl-heptadecasphingosine (d17:1/16:0) levelsGCST902001150.82
3216Pulse wave Arterial Stiffness index | Arterial stiffnessUKBB000007240.82
3217C-reactive protein levels (CRP.4337.49.2)GCST902405030.82
3218aparc-a2009s lh area S-centralGCST900033410.82
3219Alkenylphosphatidylcholine (P-36:3) levelsGCST900249540.82
3220Androsterone sulfate levelsGCST902006740.82
3221IDP dMRI TBSS L3 Sagittal stratum LGCST900042020.82
3222MITD1/RHOC ratioGCST903154530.82
3223Type 1 diabetes (PheCode 250.1)GCST904756610.81
3224Cholesteryl esters in large LDL (UKB data field 23534)GCST902696310.81
3225Cholesterol to Total Lipids in Very Large HDL percentageGCST905003330.81
3226ICD10 E28.2: Polycystic ovarian syndromeGCST904542050.81
3227Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471ECGA0004710.81
3228Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009430.81
3229NRAC levelsGCST906179910.81
3230FrecklesGCST0060910.81
3231Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468ECGA0004680.81
3232TBCB/TBCC ratioGCST903159090.81
323310-undecenoate (11:1n1) levelsGCST902435960.81
3234Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008460.81
3235Dried fruit likingGCST900947560.81
3236IDP dMRI ProbtrackX MD cgh lGCST900042250.81
3237MigraineFING000008180.81
3238Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T349ECGU0003490.80
3239Solitary pulmonary nodule (PheCode 514.2)GCST904760440.80
3240Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494ECGA0004940.80
3241IDP dMRI ProbtrackX L1 fmiGCST900042570.80
3242NT5C3A/PRDX5 ratioGCST903155670.80
3243Synonym | Fluid intelligence / reasoningUKBB000008020.80
3244Benign mammary dysplasiaFING000001510.80
3245Degree of unsaturationGCST905027370.80
3246CA11 levelsGCST904685060.80
3247Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192ECGA0001920.80
3248Pulse wave peak to peak time | Arterial stiffnessUKBB000007250.80
32491-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levelsGCST902006850.80
3250HippSubfield rh volume GC-ML-DG-bodyGCST900027030.79
3251Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463ECGA0004630.79
3252Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334ECGU0003340.79
3253DOK2/LACTB2 ratioGCST903145320.79
3254RBP2 levelsGCST904704380.79
3255Chronic osteomyelitis (PheCode 710.12)GCST904762230.79
3256Other disorders of skin and subcutaneous tissueFING000010350.79
3257CTSD/PRCP ratioGCST903143120.79
3258OsteoarthritisGCST901342790.79
3259Left-hemisphere dorsal attention network to thalamus white-matter structural connectivityGCST903027010.79
3260Main speciality of consultant (recoded) - General surgery | Summary AdministrationUKBB000004170.79
3261IDP dMRI ProbtrackX L1 ilf lGCST900042600.79
3262AGRN/BTN2A1 ratioGCST903131990.78
3263Total Lipids in LDLGCST904984050.78
3264Other mental disorders due to brain damage and dysfunction and to physical diseaseFING000010720.78
3265Fracture of upper limb (PheCode 803)GCST904762790.78
3266Free cholesterol to total lipids ratio in large HDLGCST900928490.78
3267DECR1/METAP1D ratioGCST903144480.78
3268ADAM15 levelsGCST904682170.78
3269T1 FreeSurfer a2009s lh S postcentral volumeGCST903848820.78
3270Cholesteryl ester levels in medium VLDLGCST900929180.78
3271IDP dMRI TBSS FA Posterior limb of internal capsule LGCST900038960.78
3272Volume of right paralaminar nucleusGCST904749280.78
3273F9 levelsGCST904691720.78
3274Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2)GCST901329570.77
3275CHCHD6 levelsGCST904687390.77
3276Corneal edema (PheCode 364.2)GCST904758620.77
3277Microalbumin in urine | Urine assaysUKBB000004670.77
3278CDKN1A/TXLNA ratioGCST903139790.77
3279METAP2/USP8 ratioGCST903154340.77
3280Diacylglycerol_44:7_[M+H-H2O]1+ levelsGCST900602400.77
3281aparc-a2009s rh area S-postcentralGCST900034370.77
3282HippSubfield lh volume subiculum-bodyGCST900026690.77
3283Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T351ECGU0003510.77
3284Chronic ulcer of leg or foot (PheCode 707.2)GCST904762180.77
3285Average diameter for LDL particlesGCST904984580.77
3286PLA2G4A/SNX9 ratioGCST903156700.77
3287Diacylglycerol_42:7_[M+H-H2O]1+ levelsGCST900602260.77
3288Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T219ECGA0002190.77
3289DTI TBSS MD Superior longitudinal fasciculus LGCST903846130.77
3290Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T203ECGU0002030.76
3291Total cholesterol minus HDL-C levelsGCST900929300.76
3292AmygNuclei rh volume Paralaminar-nucleusGCST900026660.76
3293ABHD14B/SCRN1 ratioGCST903131450.76
3294Cholesterol to total lipids in large HDL percentage (UKB data field 23635)GCST902697320.76
3295Pain type(s) experienced in last month - Hip pain | PainUKBB000006280.76
3296Mononeuropathies of upper limb | Nerve, nerve root and plexus disordersUKBB000004810.76
3297Left-hemisphere default mode network to accumbens white-matter structural connectivityGCST903027730.76
3298Phospholipids in large LDL (UKB data field 23532)GCST902696290.76
3299AZU1 levelsGCST904684080.76
3300Arabitol/xylitol levelsGCST902000110.76
3301Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009490.76
3302End stage renal disease (PheCode 585.32)GCST904761260.76
3303Obstructed labour due to maternal pelvic abnormalityFING000008990.76
3304ANXA3/ANXA4 ratioGCST903132780.76
3305Unspecified/other endometriosisFING000014040.76
3306Autorefraction - 3mm cylindrical power (right) | EyesightUKBB000000630.75
3307Clinical LDL cholesterol levels (UKB data field 23404)GCST902695010.75
3308Leisure/social activities - Adult education class | Social supportUKBB000003980.75
3309ADGRG2/SDC1 ratioGCST903131870.75
3310IDP dMRI ProbtrackX FA ifo lGCST900039370.75
3311Volume of right cortico-amygdaloid transition areaGCST904749110.75
3312IPCEF1/SERPINE1 ratioGCST903151840.75
3313Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026490.75
3314IL18R1 levelsGCST902416070.75
3315IDP dMRI ProbtrackX OD ilf rGCST900044650.75
3316Gamma glutamyl transpeptidaseGCST900187340.75
3317PLIN3/VSIR ratioGCST903156790.75
3318Barrett's esophagus or Esophageal adenocarcinomaGCST0037400.75
3319CTSH levelsGCST900885010.75
3320aparc-a2009s rh area G+S-occipital-infGCST900033720.74
3321Concentration of very small VLDL particlesGCST905008190.74
3322PROK2 levelsGCST906170730.74
3323ACYP1 levelsGCST904682140.74
3324Total concentration of lipoprotein particlesGCST900929900.74
3325Asthma with exacerbation (PheCode 495.2)GCST904760250.74
3326Sleep apnea (MTAG)GCST902673620.74
3327DTI TBSS L1 Body of corpus callosumGCST903844310.74
3328IDP dMRI TBSS ICVF Posterior limb of internal capsule LGCST900043460.74
3329IGSF3 levelsGCST904695390.74
3330BIRC2/CD40LG ratioGCST903135170.74
3331PDGFB levelsGCST900120160.74
3332CXCL5/EDAR ratioGCST903143490.74
3333Biological Sibling: Coronary Artery / Coronary Heart DiseaseGCST904763700.74
3334PODXL2/SDC1 ratioGCST903157010.74
3335PON2 levelsGCST904702860.74
3336Average diameter for VLDL particlesGCST900930020.74
3337T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59)GCST903208780.73
3338IPCEF1/TBCC ratioGCST903151880.73
3339Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T130ECGU0001300.73
3340CXCL14 levelsGCST904689270.73
3341T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903209000.73
3342Other septicaemiaFING000010970.73
3343Triglycerides to total lipids ratio in large LDLGCST900928670.73
3344rfMRI amplitudes (ICA100 node 40)GCST900046280.73
3345Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495ECGA0004950.73
3346mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754520.73
3347Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479ECGA0004790.73
3348Total lipid levels in HDLGCST900928250.73
3349Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430ECGU0004300.73
3350MAP4K5/TBCC ratioGCST903153850.73
3351Biological Mother: High blood pressureGCST904754900.73
3352Gastric ulcerGCST900186310.73
3353Concentration of large LDL particlesGCST904980290.73
3354HSIL lesion of the vulvaFING000006260.72
3355IL1RAP levelsGCST904695730.72
3356IDP dMRI ProbtrackX ICVF ptr rGCST900043950.72
3357AXIN1/MAP2K6 ratioGCST903134130.72
3358CXCL16 levelsGCST900120590.72
3359Atrial fibrillationGCST0064140.72
3360Alpha-hydroxyisovalerate levelsGCST901997360.72
3361Urine proline levels in chronic kidney diseaseGCST902658730.72
3362IDP dMRI TBSS L3 Posterior thalamic radiation RGCST900041990.72
3363Concentration of HDL particlesGCST900928260.72
3364Triglyceride levels in chylomicrons and extremely large VLDLGCST900930500.72
3365IDP dMRI ProbtrackX L2 ptr rGCST900042930.72
3366Reticulocyte percentage | Blood countUKBB000007530.72
3367Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422ECGU0004220.72
3368MelanomaGCST900118090.72
3369wg rh intensity-contrast temporalpoleGCST900038590.72
3370IDP dMRI TBSS ICVF FornixGCST900043320.71
3371Concentration of very large HDL particlesGCST905004360.71
3372Non-cancer illness code, self-reported - osteoarthritis | Medical conditionsUKBB000005210.71
3373DementiaFING000003910.71
3374DTI TBSS MD Retrolenticular part of internal capsule RGCST903845920.71
3375Concentration of medium HDL particlesGCST900928990.71
3376MSTN levelsGCST904699530.71
3377Cholesterol levels in very large VLDLGCST900930160.71
3378T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36)GCST903205990.71
3379Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482ECGA0004820.71
3380IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus RGCST900043690.71
3381Total lipids in very large HDLGCST905004230.71
3382LYN/YES1 ratioGCST903153510.70
3383Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998310.70
3384Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T341ECGU0003410.70
3385DTI TBSS L3 Genu of corpus callosumGCST903845260.70
3386BLMH/SERPINE1 ratioGCST903135200.70
3387Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T352ECGU0003520.70
3388PMVK/PRDX5 ratioGCST903156940.70
3389Triglycerides to total lipids ratio in IDLGCST900928420.70
3390Phospholipid levels in HDLGCST900928270.70
3391Cholesteryl esters to total lipids ratio in very small VLDLGCST900930310.70
3392N-formylmethionine levelsGCST902003430.69
3393ABHD14B/CRADD ratioGCST903131410.69
3394Handedness (confirmatory factor analysis Factor 36)GCST903093700.69
3395GFRA3/LAYN ratioGCST903149260.69
3396Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467ECGA0004670.69
3397DOK2/PPP1R12A ratioGCST903145360.69
3398Job involves shift work | EmploymentUKBB000003850.69
3399Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST904760650.69
3400Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T353ECGU0003530.69
3401Prescriptions - prostaglandin analogUKBB000006970.69
3402T1 FreeSurfer DK rh cuneus areaGCST903856930.69
3403Right-hemisphere somatomotor network to caudate white-matter structural connectivityGCST903027950.69
3404systolic blood pressure (SBP, maximum, inv-normal transformed)GCST904764000.69
3405N-delta-acetylornithine levelsGCST902006910.68
3406Prescriptions - bendroflumethiazide | thiazide diuretic,diureticUKBB000006670.68
3407Hearing aid useGCST900447740.68
3408MAPK13 levelsGCST902419490.68
3409CCN2/HBEGF ratioGCST903137130.68
3410Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T206ECGU0002060.68
3411CEBPB levelsGCST904687000.68
3412Cancer within the respiratory system (PheCode 165)GCST904755710.68
3413Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027760.67
3414NECTIN2/TNFRSF1A ratioGCST903155320.67
3415Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T99ECGA0000990.67
3416aseg global volume CC-CentralGCST900026090.67
3417DNA methylation-estimated granulocyte proportionsGCST900142870.67
3418Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditionsUKBB000005190.67
3419IDP dMRI TBSS L2 Cingulum hippocampus RGCST900041590.67
3420IDP dMRI TBSS ICVF Posterior thalamic radiation LGCST900043560.67
3421Severe, life-threatening illness (confirmatory factor analysis Factor 20)GCST903093540.67
3422TSC22D1 levelsGCST904709730.67
3423IDP dMRI ProbtrackX FA atr rGCST900039280.67
3424IDP dMRI ProbtrackX L2 ifo lGCST900042850.67
3425Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480ECGA0004800.67
3426CES3 levelsGCST904687200.67
3427CXCL17/LAMP3 ratioGCST903143400.67
3428Coronary artery calcificationGCST905030740.67
3429Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T347ECGU0003470.67
3430T1 CAT GM unnormalised volumeGCST903839820.67
3431Bursitis (PheCode 726.3)GCST904762400.67
3432MCAM/NCAM1 ratioGCST903154080.67
3433AXIN1/GOPC ratioGCST903134070.66
3434Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439ECGU0004390.66
3435Left ventricular end diastolic massGCST902681230.66
3436ALDH1A1/SORD ratioGCST903132480.66
3437Free cholesterol levels in very large VLDLGCST900930200.66
3438CA3 levelsGCST904685120.66
3439T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50)GCST903206130.66
3440Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING000012030.66
3441Glycine levelsGCST0076380.66
3442Emotional neglectGCST905518460.66
3443IDP dMRI ProbtrackX FA ilf lGCST900039390.66
3444aparc-Desikan lh volume lateraloccipitalGCST900027780.66
3445Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487ECGA0004870.66
3446Average diameter for HDL particlesGCST900928280.66
3447CTSB levelsGCST904689080.66
3448IMPA1/TBCC ratioGCST903151750.66
3449IDP dMRI TBSS L1 Cingulum hippocampus RGCST900041110.66
3450EFEMP1/IL18BP ratioGCST903145960.66
3451Atrial fibrillation and flutter | circulatory systemUKBB000000550.65
3452IDP dMRI TBSS FA Middle cerebellar peduncleGCST900038770.65
3453Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478ECGA0004780.65
3454Non-oily fish consumptionGCST901329940.65
3455High cholesterolGCST904681340.65
3456Microvirga abundance in stoolGCST900324790.65
3457OsteoporosisGCST900861220.65
3458Cholesteryl Esters in Small VLDLGCST904997860.65
3459Spondylopathies (FG)FING000013260.65
3460Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28ECGU0000280.65
3461ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrheaGCST904542190.65
3462Cerebrospinal fluid methylmalonate (MMA) levelsGCST903182430.65
3463Right-hemisphere control network to thalamus white-matter structural connectivityGCST903028360.65
3464DTI TBSS L3 Superior corona radiata RGCST903845480.65
3465METAP1D/VASH1 ratioGCST903154290.65
3466KLF4 levelsGCST904696940.65
3467Operation code - wisdom teeth surgery | OperationsUKBB000005690.65
3468BACH1/CD2AP ratioGCST903134350.65
3469Triglycerides in medium VLDLGCST904990640.64
3470Preeclampsia or other maternal hypertension (maternal genotype effect)GCST902699040.64
3471IRAG2/TBC1D23 ratioGCST903151910.64
3472Ratio of polyunsaturated fatty acids to monounsaturated fatty acidsGCST900929400.64
3473Wears glasses or contact lenses | EyesightUKBB000009070.64
3474Atrial fibrillation and flutter | Other forms of heart diseaseUKBB000000560.64
3475COL6A3/TAFA5 ratioGCST903141800.64
3476aseg global intensity WM-hypointensitiesGCST900037560.64
3477Takes medication for asthma?GCST904752600.64
3478PPM1F levelsGCST904702970.64
3479Cholelithiasis | Disorders of gallbladder, biliary tract and pancreasUKBB000001320.64
3480CirrhosisGCST900186060.64
3481Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472ECGA0004720.64
3482Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75ECGA0000750.64
3483ENG levelsGCST904691080.64
3484Disorders of plasma protein metabolism (PheCode 270.3)GCST904757090.64
3485NOS3 levelsGCST904700640.64
3486Amyotrophic lateral sclerosisGCST900271640.64
3487LDL cholesterol levels (UKB data field 23405)GCST902695020.63
3488MEGF9/OXT ratioGCST903154190.63
3489Atherosclerosis of the extremities (PheCode 440.2)GCST904759900.63
3490MUC2 levelsGCST904699650.63
3491APOA1 levelsGCST900928080.63
3492wg rh intensity-contrast rostralanteriorcingulateGCST900038520.63
3493CRADD/MAP4K5 ratioGCST903142400.63
3494ICD10 N86: Erosion and ectropion of cervix uteriGCST904542170.63
3495aparc-pial rh area parstriangularisGCST900031930.63
3496ST6GALNAC2 levelsGCST902402510.63
3497Impedance of whole body (UKB data field 23106)GCST904681730.63
3498wg rh intensity-contrast precentralGCST900038500.63
3499Pulmonary heart disease (PheCode 415)GCST904759420.63
3500PFKM levelsGCST906188020.63
3501POMC levelsGCST904702840.63
3502MigraineGCST904681420.63
3503IDP dMRI TBSS ICVF Pontine crossing tractGCST900043280.63
3504Phospholipids to Total Lipids in Small LDL percentageGCST904996900.62
3505PSCA levelsGCST904703520.62
3506C-reactive protein levels (UKB data field 30710)GCST904680640.62
3507Phospholipids to Total Lipids in Large LDL percentageGCST904980580.62
3508Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T193ECGA0001930.62
3509Cholesteryl Esters in Large HDLGCST904977530.62
3510BCL2 levelsGCST904684330.62
3511Anterior diffusion tensor imaging along the perivascular space indexGCST904555430.62
3512Left-hemisphere default mode network to thalamus white-matter structural connectivityGCST903027670.62
3513Right ventricular stroke volumeGCST901345900.62
3514Sciatica+with lumbagoFING000012790.62
3515T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70)GCST903208890.62
35164-acetamidobutanoate levelsGCST902434400.62
3517X-04499--3,4-dihydroxybutyrate levelsGCST902434970.62
3518Carnitine levelsGCST902434810.62
3519aparc-a2009s lh volume G-precentralGCST900029530.62
3520Cervical cancerGCST900118160.62
3521Panic attacks | Mental distressUKBB000006340.61
3522Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T346ECGU0003460.61
3523COL3A1 levelsGCST904688170.61
3524Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T238ECGA0002380.61
3525Free Cholesterol to Total Lipids in Very Large HDL percentageGCST905003970.61
3526AHNAK levelsGCST904682610.61
3527Free cholesterol levels in large VLDLGCST900928720.61
3528Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T237ECGU0002370.61
3529SEMA3F levelsGCST904705700.61
3530Free Cholesterol in LDLGCST904983860.61
3531Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329310.61
3532Free Cholesterol to Total Lipids in Medium LDL percentageGCST904987830.61
3533Isolated hypothyroxinemia in pregnancyGCST904351980.60
3534Urine dimethylglycine levels in chronic kidney diseaseGCST902650450.60
3535CD164 levelsGCST904686020.60
3536SNAP25 levelsGCST904706910.60
3537Left ventricular end systole inferoseptal wall thicknessGCST902785080.60
3538Total cholesterol minus HDL-C levels (UKB data field 23401)GCST902694980.60
3539Treatment/medication code - bendroflumethiazide | MedicationsUKBB000008430.60
3540Idiopathic pulmonary fibrosisGCST903997200.60
3541KeratoconusFING000007090.60
3542Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72ECGA0000720.60
3543HippSubfield rh volume CA3-bodyGCST900027020.60
3544MMP8 levelsGCST904699220.60
3545DNA methylation GrimAge accelerationGCST900142880.60
3546Cholesteryl Esters in LDLGCST904983630.60
3547IDP dMRI ProbtrackX L2 ar lGCST900042730.60
3548IDP dMRI TBSS L2 Middle cerebellar peduncleGCST900041230.59
3549CA2/CA3 ratioGCST903135760.59
3550Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340ECGU0003400.59
3551Urine betaine levels in chronic kidney diseaseGCST902648590.59
3552Follicular lymphoma, hilmo (controls excluding all cancers)FING000005480.59
3553Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T194ECGA0001940.59
3554Cholesterol in Large VLDLGCST904981230.59
3555Left ventricular end diastolic volume (indexed to body surface area)GCST904352580.59
3556IDP dMRI TBSS ICVF Fornix cres+Stria terminalis RGCST900043650.59
3557CKMT1A or CKMT1B levelsGCST904687600.59
3558Plasma argininate* levels in chronic kidney diseaseGCST902648260.59
3559NFATC1/TJAP1 ratioGCST903155400.59
3560Other follicular disordersFING000010500.59
3561Free cholesterol in large VLDLGCST904981810.59
3562Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivityGCST903027200.59
3563Cholesterol in very small VLDL (UKB data field 23519)GCST902696160.59
3564TF levelsGCST904708410.59
3565DTI autoptx L1 slf l tractGCST903851600.59
3566CA1/CA2 ratioGCST903135710.59
3567CNTN3/FETUB ratioGCST903141640.59
3568Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST900929430.59
3569Phospholipids to total lipids ratio in medium VLDLGCST900929250.59
3570Sphingomyelin_34:1_[M+H]1+ levelsGCST900602390.59
3571T1 FreeSurfer BA lh V2 exvivo thicknessGCST903855290.58
3572Phosphatidylcholine (34:5) levelsGCST900242860.58
3573Benign neoplasm of eye, uveal (PheCode 224.1)GCST904756290.58
3574IL13RA1 levelsGCST904695520.58
3575Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney diseaseGCST902643210.58
3576Atrial fibrillation and flutter (PheCode 427.2)GCST900439770.58
3577CDH2 levelsGCST904686730.58
3578Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979690.58
3579PDLIM5 levelsGCST904701970.58
3580Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62ECGA0000620.58
3581ANPEP/NT5E ratioGCST903132740.58
3582Cholesterol in Large HDLGCST904977190.58
3583Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583)GCST902696800.58
3584Restless leg syndromeFING000012550.58
3585APOB levelsGCST904971300.58
3586DTX3 levelsGCST904690480.58
3587BA-exvivo lh thickness BA4pGCST900035180.58
3588mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754580.58
3589GABARAPL1 levelsGCST904692870.58
3590ThalamNuclei rh volume PuIGCST900027380.57
3591Lung cancerGCST900118120.57
3592Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001790.57
3593IDP dMRI TBSS ISOVF External capsule LGCST900045100.57
3594Volume of right paralaminar nucleusGCST904750510.57
3595CCS levelsGCST904685940.57
3596S100A14 levelsGCST904705150.57
3597Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469ECGA0004690.57
3598IDP dMRI TBSS MD Retrolenticular part of internal capsule RGCST900040470.57
3599Sphingomyelin_34:0_[M+H]1+ levelsGCST900602410.57
3600CHMP1A/EREG ratioGCST903140480.57
3601LDL cholesterol levelsGCST900928830.57
3602Plasma betaine levels in chronic kidney diseaseGCST902648580.57
3603IDP dMRI TBSS ICVF Tapetum LGCST900043740.57
3604Postinflammatory pulmonary fibrosis (PheCode 502)GCST904760320.57
3605Cholesterol in Large LDLGCST904979190.57
3606Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003730.57
3607IDP dMRI TBSS L3 Inferior cerebellar peduncle RGCST900041810.57
3608EDAR/IRAK4 ratioGCST903145790.56
3609T1 FreeSurfer a2009s rh S temporal sup volumeGCST903851100.56
3610Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900241970.56
3611Atrial fibrillation (MTAG)GCST904490540.56
3612HGF/MMP9 ratioGCST903150560.56
3613Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001780.56
3614Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432ECGU0004320.56
3615IDP dMRI ProbtrackX L1 str lGCST900042690.56
3616Acetone levelsGCST900928050.56
3617Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336ECGU0003360.56
3618Concentration of medium LDL particlesGCST904988230.56
3619SMOC2 levelsGCST900600590.56
3620Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40ECGA0000400.56
3621PDGFA/SERPINE1 ratioGCST903156180.56
3622Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27ECGU0000270.56
3623PDGFRB levelsGCST904701920.56
3624aparc-a2009s rh area G-pariet-inf-SupramarGCST900033960.56
3625Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB000006940.56
3626Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB000007060.56
3627HGS levelsGCST904694500.55
3628MCAM levelsGCST904698700.55
3629Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T342ECGU0003420.55
3630rfMRI connectivity (ICA100 edge 619)GCST900054720.55
3631Cholesterol in medium VLDL (UKB data field 23505)GCST902696020.55
3632aparc-Desikan lh area rostralmiddlefrontalGCST900030990.55
36335,6-dihydrouridine levelsGCST901997670.55
3634LEPR levelsGCST904697560.55
3635Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB000001920.55
3636Leg predicted mass (right) | Impedance measuresUKBB000003970.55
3637IDP dMRI TBSS L1 Anterior limb of internal capsule RGCST900040910.55
3638DSG2 levelsGCST904278250.55
3639EndometriosisFING000004970.55
3640CD74/IL18BP ratioGCST903138920.55
3641S100A11 levelsGCST904705120.55
3642Primary Raynaud’s phenomenonGCST902717140.55
3643Phosphatidylcholine diacyl C38:3 levelsGCST902400450.55
3644Cholesterol in Large VLDLGCST904981190.55
3645Cholesteryl Esters in VLDLGCST905002050.55
3646CHI3L1/HSPG2 ratioGCST903140430.55
3647Total cholines levels (UKB data field 23436)GCST902695330.55
3648LifespanGCST905518850.54
3649Cholesterol in Large LDLGCST904979230.54
3650EGFLAM levelsGCST904216510.54
3651EFNA4/LAYN ratioGCST903146020.54
3652aparc-pial rh area lateralorbitofrontalGCST900031850.54
3653Leg fat-free mass (right) | Impedance measuresUKBB000003940.54
3654IDP dMRI TBSS L3 Sagittal stratum RGCST900042010.54
3655NGRN levelsGCST904700450.54
3656Basal metabolic rate | Impedance measuresUKBB000000860.54
3657Chronic hepatitis C infectionGCST900185850.54
3658DRG2/SEMA4D ratioGCST903145540.54
3659IDP dMRI TBSS L2 Inferior cerebellar peduncle RGCST900041330.54
3660Ascending aorta diameterGCST900910500.54
3661Acetate levelsGCST900928030.54
3662rfMRI connectivity (ICA100 edge 495)GCST900053480.54
3663Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney diseaseGCST902647960.54
3664Phosphatidylglycerol (34:1) levelsGCST900250610.54
3665aseg lh volume PallidumGCST900026230.54
3666SPON2 levelsGCST904707320.54
3667Benign neoplasm: Rectum, anus and anal canalFING000001970.54
3668Cholesterol levels in medium VLDLGCST900929160.54
3669Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231ECGU0002310.54
3670All pneumoniaeFING000000650.53
3671Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levelsGCST900603260.53
3672Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473ECGA0004730.53
3673Potatoes likingGCST900948160.53
3674Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992880.53
3675FLT1/TFPI2 ratioGCST903148560.53
3676CNTNAP2 levelsGCST904688080.53
3677Uterine fibroidsGCST904681540.53
3678Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97ECGA0000970.53
3679Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T492ECGA0004920.53
3680Vascular/heart problems diagnosed by doctor - None of the above | Medical conditionsUKBB000008990.53
3681IridocyclitisFING000006960.53
3682Nasal polyp | Other diseases of upper respiratory tractUKBB000004930.53
36832-hydroxyisobutyrate levelsGCST902435390.53
3684Concentration of large LDL particlesGCST900928630.53
3685Low density lipoprotein cholesterol levelsGCST902396570.53
3686Phospholipid levels in large VLDLGCST900928760.52
3687Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivityGCST903027920.52
3688Other diseases of the respiratory systemFING000010110.52
3689EREG/GYS1 ratioGCST903147010.52
3690SPINT2/TNFSF13 ratioGCST903158790.52
3691NSFL1C/PSMG3 ratioGCST903155590.52
3692Abdominal subcutaneous adipose tissueGCST902673470.52
3693Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024150.52
3694Visceral adipose tissueGCST902673570.52
3695DFFA/FOXO1 ratioGCST903144560.52
3696SnoringGCST0097600.52
3697IDP dMRI TBSS ICVF Sagittal stratum RGCST900043570.52
3698Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424ECGU0004240.52
3699Total lipid levels in LDLGCST900928860.52
3700Coronary atherosclerosis (PheCode 411.4)GCST904759360.52
3701O-sulfo-l-tyrosine levelsGCST902436230.52
3702IDP dMRI TBSS L1 Anterior limb of internal capsule LGCST900040920.51
3703T1 FIRST volume L PutaGCST903839870.51
3704HealthspanGCST0074060.51
3705Total lipid levels in chylomicrons and extremely large VLDLGCST900930460.51
3706Phospholipid levels in very large VLDLGCST900930240.51
3707aparc-a2009s lh area S-temporal-supGCST900033690.51
3708Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189ECGU0001890.51
3709SLIT2 levelsGCST904706680.51
3710Maximum heart rate during fitness test | ECG during exerciseUKBB000004310.51
3711Right-hemisphere control network to putamen white-matter structural connectivityGCST903028380.51
3712Olsenella C abundance in stoolGCST900324930.51
3713KIAA0319 levelsGCST904696760.51
3714Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69ECGA0000690.51
3715Osteoarthrosis NOS (PheCode 740.9)GCST904762560.51
3716Deforming dorsopathiesFING000003850.50
3717MCEMP1 levelsGCST904698720.50
3718PLAU/PLAUR ratioGCST903156740.50
3719Benign neoplasm: ColonFING000001710.50
3720IDP dMRI ProbtrackX L3 unc lGCST900043250.50
3721Triglyceride levels in chylomicrons and extremely large VLDLGCST905010750.50
3722PDCD1/TNFRSF9 ratioGCST903156110.50
3723Chronic sinusitis (PheCode 475)GCST904760200.50
3724IDP dMRI TBSS L3 Anterior limb of internal capsule RGCST900041870.50
3725Dermatomycosis (PheCode 110.2)GCST904755650.50
3726FNDC1 levelsGCST904692560.50
3727IDP T1 SIENAX CSF unnormalised volumeGCST900024290.50
3728DTI TBSS MD Splenium of corpus callosumGCST903845760.50
3729ATP5IF1/FXN ratioGCST903133860.50
3730Concentration of LDL particlesGCST904984180.50
3731TMSB10/ZBTB16 ratioGCST903159260.50
3732Anorexia (incl.atypical)FING000000930.50
3733IGFBP1 levelsGCST904695270.50
3734Right ventricular end systolic volumeGCST902681180.50
3735PPP1R2/TBL1X ratioGCST903157200.50
3736X-12095--N1-methyl-3-pyridone-4-carboxamide levelsGCST902437010.50
3737Frequency of heavy DIY in last 4 weeks | Physical activityUKBB000002630.50
3738aparc-a2009s rh area S-oc-middle+LunatusGCST900034270.49
3739Left-hemisphere control network to putamen white-matter structural connectivityGCST903027540.49
3740IDP dMRI ProbtrackX MD cgc lGCST900042230.49
3741Cholesterol in Small VLDLGCST904997500.49
3742T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48)GCST903206110.49
3743GLB1 levelsGCST904693550.49
3744METAP2/PFKFB2 ratioGCST903154310.49
3745Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485ECGA0004850.49
3746Arthropathies in other diseases classified elsewhereFING000001080.49
3747DBI/MESD ratioGCST903144090.49
3748CRELD2/NUCB2 ratioGCST903142560.49
3749LDL direct | Blood biochemistryUKBB000003860.49
3750Hypertrophy of breast in women and menFING000006450.49
3751Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402)GCST902694990.49
3752EFNA1/PIK3IP1 ratioGCST903145980.49
3753Acute alcohol intoxication, ICD10FING000000150.49
3754IFNGR2 levelsGCST904695140.49
3755EIF4B/IPCEF1 ratioGCST903146220.48
3756DTI TBSS MD Retrolenticular part of internal capsule LGCST903845930.48
3757Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238ECGU0002380.48
3758DTI autoptx L3 str l tractGCST903852160.48
3759Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191ECGA0001910.48
3760CLEC1B/SNAP29 ratioGCST903141030.48
3761GanglionFING000005630.48
3762Other specified/unspecified inflammatory spondylopathiesFING000011090.48
3763DTI autoptx L1 slf r tractGCST903851610.48
3764ALCAM/SPINT1 ratioGCST903132420.48
3765Pizza likingGCST900948100.48
3766IDP T1 SIENAX CSF normalised volumeGCST900024280.48
3767Testosterone levels (UKB data field 30850)GCST904681030.48
3768Lichen simplex chronicus and prurigoFING000007250.48
3769rfMRI connectivity (ICA100 edge 961)GCST900058140.48
3770MSRA levelsGCST904699510.48
3771Cholesterol in Medium VLDLGCST904989090.48
3772TLR4 levelsGCST904708800.48
3773aseg lh intensity Lateral-VentricleGCST900037640.48
3774CA14 levelsGCST904685090.48
3775Phosphatidylcholine acyl-alkyl C36:5 levelsGCST902400730.48
3776Viral and other specified intestinal infectionsFING000014320.47
3777IDP dMRI ProbtrackX ISOVF str lGCST900045480.47
3778IDP dMRI ProbtrackX MD unc lGCST900042440.47
3779Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338ECGU0003380.47
3780Crohn disease (strict definition, require KELA, min 2 HDR)FING000003660.47
3781Osteoarthritis, localized (PheCode 740.1)GCST904762540.47
3782Linoleic acid levelsGCST905023100.47
3783Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71ECGA0000710.47
3784OSCAR/TNFRSF14 ratioGCST903155880.47
3785MOG/RTBDN ratioGCST903154760.47
3786Crohn's disease of small intestineFING000003690.47
3787Free cholesterol in small VLDLGCST904998170.47
3788Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levelsGCST900602800.47
3789Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027990.47
3790Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivityGCST903027350.46
3791SYT1 levelsGCST904707940.46
3792Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)GCST902697390.46
3793Cholesterol to Total Lipids in Medium LDL percentageGCST904987230.46
3794Total cholines levelsGCST900928120.46
3795Benign neoplasm of colon, rectum, anus and anal canalFING000001550.46
3796CLEC1A levelsGCST904242310.46
3797Hemoglobin A1c (HbA1c, mean, inv-norm transformed)GCST904750940.46
3798KIR3DL1 levelsGCST904696870.46
3799Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498ECGU0004980.46
3800IDP dMRI TBSS MD Cingulum cingulate gyrus LGCST900040620.46
3801GZMA/GZMB ratioGCST903150070.46
3802Benign neoplasm: Adrenal glandFING000001640.46
3803DPEP1 levelsGCST900903020.46
3804Volume of right cortico-amygdaloid transition areaGCST904749130.46
3805HYOU1/RARRES2 ratioGCST903151030.46
3806Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST903026730.46
3807HSIL lesion of the cervix uteri, vagina or vulvaFING000006250.46
3808PCDH1 levelsGCST904701700.46
3809MAP3K5/ZBTB16 ratioGCST903153800.46
3810Omega-3 fatty acid levelsGCST905024250.45
3811Left-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903026870.45
3812T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903206720.45
3813PDGFB/TIMP3 ratioGCST903156310.45
3814Blood cell traits latent factor 17 (white cell)GCST905592590.45
3815T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903209110.45
3816IDP dMRI TBSS ISOVF External capsule RGCST900045090.45
3817DTI TBSS MD Uncinate fasciculus RGCST903846160.45
3818Heart attackGCST904752110.45
3819Triglycerides to total lipids in IDL percentage (UKB data field 23613)GCST902697100.45
3820TANK levelsGCST904708030.45
3821Cholesterol to total lipids ratio in very small VLDLGCST900930290.45
3822IDP dMRI TBSS ICVF Retrolenticular part of internal capsule RGCST900043470.45
3823IDP dMRI ProbtrackX ISOVF ifo lGCST900045370.45
3824Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023990.45
3825CLSTN2 levelsGCST904687890.45
3826Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000001750.45
3827Free Cholesterol to Total Lipids in Large LDL percentageGCST904980000.44
3828PTPRB levelsGCST904703790.44
3829T1 FreeSurfer aseg Left-Inf-Lat-VentGCST903841400.44
3830Arm fat-free mass (left) | Impedance measuresUKBB000000470.44
3831Polyneuropathy in diabetes (PheCode 250.6)GCST904756860.44
3832Triglycerides to total lipids in large LDL percentage (UKB data field 23618)GCST902697150.44
3833HypertensionGCST900860910.44
3834APOB levelsGCST900928090.44
3835Sleep related movement disorders (PheCode 327.7)GCST904758270.44
3836Erectile dysfunctionGCST0069560.44
3837Omega-6 fatty acids to total fatty acids percentageGCST904992030.44
3838IDP dMRI TBSS MD Posterior corona radiata RGCST900040530.44
3839REST UKBBICA NODEamps25 0007GCST903854900.44
3840Omega-3 fatty acids to total fatty acids percentageGCST905024670.44
3841Free cholesterol levels in chylomicrons and extremely large VLDLGCST900930440.44
3842Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339ECGU0003390.44
3843Right-hemisphere default mode network to thalamus white-matter structural connectivityGCST903028440.44
3844MDH1 levelsGCST904698760.43
3845DTI autoptx FA slf l tractGCST903851330.43
3846Hereditary ataxiaFING000006100.43
3847Low hand grip strength (60 years and older) (EWGSOP)GCST900075260.43
3848CANT1/VSIR ratioGCST903136210.43
3849Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)GCST902697360.43
3850SCG2 levelsGCST904705380.43
3851Hypertensive heart and/or renal disease (PheCode 401.2)GCST904759240.43
3852Ceramide (d18:2/22:0) levelsGCST900246820.43
3853Cataract (PheCode 366)GCST900437850.43
3854Systolic blood pressureGCST904727820.43
3855CD177 levelsGCST904686030.43
3856Total lipid levels in large VLDLGCST900928740.43
3857REG4/SPINK4 ratioGCST903157660.43
3858CD58/IL10RB ratioGCST903138500.43
3859CD40LG/MPIG6B ratioGCST903138250.43
3860Left ventricular mass (indexed to body surface area)GCST904352600.43
3861Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86ECGU0000860.43
3862EREG/TIMP3 ratioGCST903147080.43
3863Hemoglobin A1c (HbA1c, minimum, inv-norm transformed)GCST904750970.43
3864DTI autoptx L2 slf l tractGCST903851870.43
3865Phospholipid levels in chylomicrons and extremely large VLDLGCST900930480.43
3866AIFM1/PLXNA4 ratioGCST903132200.43
3867IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosisGCST902757890.43
3868Left-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903027500.43
3869Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000001740.43
3870NEFL levelsGCST904700240.42
3871IDP dMRI ProbtrackX L3 atr rGCST900043030.42
3872BA-exvivo lh thickness BA4aGCST900035170.42
3873ANXA3 levelsGCST904683180.42
3874DTI TBSS L2 Retrolenticular part of internal capsule LGCST903844970.42
3875AV-blockFING000001370.42
3876MENT levelsGCST904698860.42
3877HGF/TNFSF14 ratioGCST903150600.42
3878Atherosclerosis (PheCode 440)GCST904759890.42
3879RGS18 levelsGCST902426170.42
3880rfMRI connectivity (ICA100 edge 1090)GCST900059430.42
3881ANXA10 levelsGCST904683140.42
3882Total lipids in LDL (UKB data field 23425)GCST902695220.42
3883GRAP2/PTPN6 ratioGCST903149860.42
3884Atrial septal defectFING000001280.42
3885DTI TBSS MD Anterior corona radiata LGCST903845950.42
3886Total lipids in very small VLDLGCST905008100.42
3887Concentration of large VLDL particlesGCST900928750.41
3888Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903027230.41
3889T1 CAT volume L LeftPutamenGCST903841000.41
3890heart rate (HR, mean, inv-normal transformed)GCST904763380.41
3891DTI autoptx L1 fmi tractGCST903851500.41
3892IDP dMRI TBSS L2 Tapetum LGCST900041700.41
3893DTI TBSS L2 Posterior corona radiata RGCST903845020.41
3894Chronic sputum productionGCST902699020.41
3895KRT8 levelsGCST904697200.41
3896Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486ECGA0004860.41
3897T1 FreeSurfer BA rh BA3a exvivo thicknessGCST903855630.41
3898Descending aorta strainGCST902673890.41
3899Mean corpuscular volumeGCST900023350.41
3900Phospholipids to Total Lipids in Very Large HDL percentageGCST905004720.41
3901Total phospholipids in lipoprotein particles (UKB data field 23411)GCST902695080.41
3902Omega-3 fatty acids to total fatty acids percentageGCST905020880.41
3903NSFL1C/RILP ratioGCST903155600.41
3904IDP dMRI TBSS MD Retrolenticular part of internal capsule LGCST900040480.41
3905Cholesterol | Blood biochemistryUKBB000001340.41
3906Triglyceride levels in large VLDLGCST900928780.41
3907rfMRI connectivity (ICA100 edge 1011)GCST900058640.41
3908Cholesterol levels in chylomicrons and extremely large VLDLGCST900930400.41
3909CALB2 levelsGCST904685270.41
3910CLK2 levelsGCST902409750.41
3911EGFR levelsGCST904690850.41
3912CardiomyopathyFING000002500.40
3913wg lh intensity-contrast inferiorparietalGCST900037990.40
3914TNF/TNFRSF1B ratioGCST903159420.40
3915Financial situation satisfaction | Mental healthUKBB000002490.40
3916Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026760.40
3917Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259ECGA0002590.40
3918Total lipids in small LDLGCST904996560.40
3919GYS1/PPP1R2 ratioGCST903150010.40
3920Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T239ECGA0002390.40
3921Docosahexaenoic acid levelsGCST905022590.40
3922Principal component-derived dietary pattern 30GCST901330350.40
3923Free cholesterol in very large VLDLGCST905005810.40
3924CDH2/SSC4D ratioGCST903139510.40
3925T1 CAT volume L CingulateGyrusanteriordivisionGCST903840560.40
3926Skin yellow/blue componentGCST903202590.40
3927CLEC4G/MERTK ratioGCST903141210.40
3928Cholesterol in Small LDLGCST904995550.40
3929Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84ECGA0000840.40
3930Operative procedures - Primary total prosthetic replacement of knee joint using cement | Summary OperationsUKBB000005880.40
3931SPARC/TJAP1 ratioGCST903158730.40
3932Asthma, unspecified (mode)FING000001200.40
3933CFD levelsGCST904687250.40
3934IL22RA2 levelsGCST900906990.40
3935Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77ECGA0000770.40
3936CSF1/SEMA3F ratioGCST903142880.39
3937PHOSPHO1 levelsGCST904702270.39
3938PMVK/RHOC ratioGCST903156970.39
3939Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499ECGU0004990.39
3940Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454)GCST902695510.39
3941DNAJC9 levelsGCST904690180.39
3942Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39ECGA0000390.39
3943Coronary artery calcificationGCST902784560.39
3944CTSC/PLA2G15 ratioGCST903143110.39
3945wg lh intensity-contrast precentralGCST900038150.39
3946CAG-776 abundance in stoolGCST900322970.39
3947SERPINE1/SMAD1 ratioGCST903158330.39
3948ACADSB levelsGCST904681950.39
3949aseg lh volume Lateral-VentricleGCST900026160.39
3950Mean corpuscular hemoglobinGCST900023230.39
3951Central pulse pressureGCST902673870.39
3952Radial styloid tenosynovitis [de Quervain]FING000012370.38
3953PCDH1/TNFRSF11A ratioGCST903156080.38
3954SFRP1 levelsGCST904706100.38
3955Cholesteryl esters in LDL (UKB data field 23417)GCST902695140.38
3956Cholesterol levels in chylomicrons and extremely large VLDLGCST905009050.38
3957Myocardial fractal dimension (slice 4)GCST900002900.38
3958CD93/CLEC14A ratioGCST903139210.38
3959Fasting blood glucoseGCST0005680.38
3960Nasal polyps | respiratoryUKBB000004940.38
3961ESAM/LAMA4 ratioGCST903147130.38
3962GLT25D1 levelsGCST904264210.38
3963Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)FING000008650.38
3964Parental longevity (combined parental attained age, Martingale residuals)GCST0066970.38
3965Phlebitis and thrombophlebitis (PheCode 451)GCST904760030.38
3966Cholesteryl Esters in Large VLDLGCST904981540.38
3967DTI TBSS L2 External capsule LGCST903845090.38
3968aparc-DKTatlas lh area rostralmiddlefrontalGCST900032590.37
3969INPP1 levelsGCST904696160.37
3970CRKL/SERPINB1 ratioGCST903142720.37
3971End-diastolic bi-ventricular shape (principal component 10)GCST904484890.37
3972ENO2/SCRN1 ratioGCST903146680.37
3973Concentration of chylomicrons and extremely large VLDL particlesGCST900930470.37
3974aparc-a2009s lh thickness G-cuneusGCST900036130.37
3975AXIN1/ITGB1BP2 ratioGCST903134120.37
3976Asparagine levelsGCST902437580.37
3977DAB2/FKBP5 ratioGCST903143630.37
3978Volume of right medial nucleusGCST904750450.37
3979PPP2R2A levelsGCST906181220.37
3980ADAMTS8/FAP ratioGCST903131720.37
3981NUDT2 levelsGCST904701060.37
3982DTI TBSS L3 Sagittal stratum RGCST903845540.37
3983QC rfMRI-to-T1 linear alignment discrepancyGCST900063530.37
3984PDCD6 levelsGCST904701830.37
3985Phosphatidylcholine-2O_32:0_[M+H]1+ levelsGCST900602440.37
3986Phospholipids to total lipids in small VLDL percentage (UKB data field 23599)GCST902696960.37
3987Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST900930420.37
3988Osteoporosis (PheCode 743.1)GCST904763840.37
3989Pre-eclampsia or eclampsiaFING000012010.37
3990Flavonifractor sp002159265 abundance in stoolGCST900324000.37
3991Diseases of oesophagus, stomach and duodenumFING000004280.37
3992Triglycerides to total lipids in small HDL percentage (UKB data field 23648)GCST902697450.36
3993Omega-3 fatty acid levelsGCST905020610.36
3994aparc-a2009s lh area S-postcentralGCST900033630.36
3995Heart valve disorders (PheCode 395)GCST904759130.36
3996IDP dMRI ProbtrackX ISOVF slf rGCST900045470.36
3997CDKN1A/PLA2G4A ratioGCST903139740.36
3998T1 CAT volume R RightAccumbensGCST903841090.36
3999Coronary heart diseaseGCST0009980.36
4000RILP levelsGCST904704710.36